Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2018-12-01
|
Series: | Gastroenterology Review |
Online Access: | https://www.termedia.pl/Empagliflozin-promises-to-bridge-the-gap-between-non-alcoholic-fatty-liver-disease-type-2-diabetes-r-nand-cardiovascular-disease,41,34212,1,1.html |